Comparable stake leader
V-Co Investors 3 LLC
SEC ownership of Vivos Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001716166.
Disclosed value leader
Michael C. Skaff
Comparable rows
28/38
Latest evidence
14 Sep 2026
- Public ticker
- VVOS on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
V-Co Investors 3 LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
28 of 38
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
V-Co Investors 3 LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
14 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001716166
- Issuer location
- Littleton, CO
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Vivos Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
V-Co Investors 3 LLC
Disclosed value leader
Michael C. Skaff
Comparable rows
28/38
Latest evidence
14 Sep 2026
3/4/5
13D/G
13F
Lead comparable stake: 20%
10 rows are not safely comparable across share classes.
13D/G row: V-Co Investors 3 LLC
Showing 1-8 of 38 holder rows.
Quick read
V-Co Investors 3 LLC leads the comparable SEC ownership view at 20%.
28 of 38 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens V-Co Investors 3 LLC's linked filing trail.
Comparable ownership
Top 5
V-Co Investors 3 LLC
20%
V-CO Investors LLC
20%
V-Co Investors 4 LLC
20%
Dawei Luo
8.5%
INTRACOASTAL CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 38 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| V-Co Investors 3 LLC |
3/4/5
13D/G
10%+ Owner · Michael C. Skaff
|
20%
from 13D/G
|
$8,766,191
6,704,371 shares
mixed-class rows
|
+$7,170,000 | 31 Mar 2026 |
| V-CO Investors LLC |
13D/G
SP Manager LLC
|
20%
|
$4,188,594
1,342,498 shares
|
+$2,583,360 | 09 Jun 2025 |
| V-Co Investors 4 LLC |
13D/G
Michael C. Skaff
|
20%
|
$1,363,163
2,783,102 shares
|
$0 | 30 Jun 2026 |
| Dawei Luo |
13D/G
|
8.5%
|
$3,432,096
572,016 shares
|
$0 | 08 Jul 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$796,804
297,315 shares
|
$0 | 22 Dec 2024 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$350,282
729,755 shares
|
-$185,330 | 30 Jun 2026 |
| Streeterville Capital LLC |
13D/G
|
0.6%
|
$38,119
122,963 shares
|
-$523,611 | 03 Sep 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.41%
|
$38,632
85,001 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$17,540,219.
Buys
$17,540,219
Insiders: 2
Sells
$0
Insiders: 0
Net
+$17,540,219
Shares: +16,200,152
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 16,200,152
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 5,498,660 | 0 | $3,200,220 | $0 | +$3,200,220 |
| 6-9 | 10,701,492 | 0 | $14,339,999 | $0 | +$14,339,999 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Vivos Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Michael C. Skaff
Net 12M change
+$17,540,220
Latest report
14 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael C. Skaff | 10%+ Owner | $13,713,037 | +$10,370,220 | +310% | Mixed | 30 Jun 2026 |
| V-Co Investors 3 LLC | 10%+ Owner | $8,766,191 | +$7,170,000 | +449% | Mixed | 31 Mar 2026 |
| Gurdev Dave Singh | Chief Medical Officer, Director, 10%+ Owner | $1,728,844 | Mixed | 05 Aug 2021 | ||
| Ronald Kirk Huntsman | Chief Executive Officer, Director | $979,026 | Mixed | 30 Jun 2026 | ||
| Bradford K. Amman | Principal Accounting Officer | $579,139 | Mixed | 31 Jul 2026 | ||
| Leonard J. Sokolow | Director | $17,771 | Mixed | 14 Sep 2026 | ||
| Matthew Thompson | Director | $16,819 | Mixed | 20 Jun 2024 | ||
| Mark F. Lindsay | Director | $16,819 | Mixed | 20 Jun 2024 | ||
| Ralph Elias Green | Director | $16,819 | Mixed | 20 Jun 2024 | ||
| Anja B. Krammer | Director | $16,819 | Mixed | 20 Jun 2024 | ||
| Gregg C. Johnson | Director | $10,689 | Mixed | 14 Sep 2026 | ||
| V-Co Investors 4 LLC | 10%+ Owner | Mixed | 30 Jun 2026 |
Recent insider transactions for Vivos Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Leonard J. Sokolow | VVOS | Stock Options (Right to Buy) | Award | 214.3% | 12,000 | 17,600 | 14 Sep 2026 | Direct | ||
| Gregg C. Johnson | VVOS | Stock Options (Right to Buy) | Award | 12,000 | 12,000 | 14 Sep 2026 | Direct | |||
| Bradford K. Amman | VVOS | Common Stock | Award | 312500% | 250,000 | 250,080 | 31 Jul 2026 | Direct | ||
| Bradford K. Amman | VVOS | Stock Option (Right to Buy) | Award | 85% | 150,000 | 326,533 | 31 Jul 2026 | Direct | ||
| Ronald Kirk Huntsman | VVOS | Preferred Stock | Other | 85,910 | 85,910 | 30 Jun 2026 | See footnote | |||
| Ronald Kirk Huntsman | VVOS | Warrant (Right to Buy) | Other | 85,910 | 85,910 | 30 Jun 2026 | See footnote | |||
| Michael C. Skaff | VVOS | Common Stock Purchase Warrant | Purchase | $1,600,110 | $0.5820 | 2,749,330 | 2,749,330 | 30 Jun 2026 | By V-Co Investors 4 LLC | |
| Michael C. Skaff | VVOS | Series A Convertible Preferred Stock | Purchase | $1,600,110 | $0.5820 | 2,749,330 | 2,749,330 | 30 Jun 2026 | By V-Co Investors 4 LLC | |
| Skaff Michael C | VVOS | Common Stock | Purchase | $1,813,858 | $1.34 | 1,353,625 | 1,353,625 | 31 Mar 2026 | By V-CO Investors 3 LLC | |
| Michael C. Skaff | VVOS | Common Stock | Purchase | $1,813,858 | $1.34 | 1,353,625 | 1,353,625 | 31 Mar 2026 | By V-CO Investors 3 LLC | |
| Skaff Michael C | VVOS | Series B Common Stock Warrant | Purchase | $2,390,000 | $1.34 | 1,783,582 | 1,783,582 | 31 Mar 2026 | By V-Co Investors 3 LLC | |
| Michael C. Skaff | VVOS | Series B Common Stock Warrant | Purchase | $2,390,000 | $1.34 | 1,783,582 | 1,783,582 | 31 Mar 2026 | By V-Co Investors 3 LLC | |
| Skaff Michael C | VVOS | Series A Common Stock Warrant | Purchase | $2,390,000 | $1.34 | 1,783,582 | 1,783,582 | 31 Mar 2026 | By V-CO Investors 3 LLC | |
| Michael C. Skaff | VVOS | Series A Common Stock Warrant | Purchase | $2,390,000 | $1.34 | 1,783,582 | 1,783,582 | 31 Mar 2026 | By V-CO Investors 3 LLC | |
| Skaff Michael C | VVOS | Pre-Funded Warrant | Purchase | $576,142 | $1.34 | 429,957 | 429,957 | 31 Mar 2026 | By V-CO Investors 3 LLC | |
| Michael C. Skaff | VVOS | Pre-Funded Warrant | Purchase | $576,142 | $1.34 | 429,957 | 429,957 | 31 Mar 2026 | By V-CO Investors 3 LLC |
* marks a reported price that did not pass the local price check.